Related references
Note: Only part of the references are listed.Doxorubicin and CpG loaded liposomal spherical nucleic acid for enhanced Cancer treatment
Bo Deng et al.
JOURNAL OF NANOBIOTECHNOLOGY (2022)
Lymph node-targeted neoantigen nanovaccines potentiate anti-tumor immune responses of post-surgical melanoma
Yanhong Chu et al.
JOURNAL OF NANOBIOTECHNOLOGY (2022)
Intracellular aggregation of peptide-reprogrammed small molecule nanoassemblies enhances cancer chemotherapy and combinatorial immunotherapy
Jinrong Peng et al.
ACTA PHARMACEUTICA SINICA B (2021)
Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
Eryn Blass et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Modularly Programmable Nanoparticle Vaccine Based on Polyethyleneimine for Personalized Cancer Immunotherapy
Jutaek Nam et al.
ADVANCED SCIENCE (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020
Wei Cao et al.
CHINESE MEDICAL JOURNAL (2021)
PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy
Julia Koerner et al.
NATURE COMMUNICATIONS (2021)
A Review of Cancer Immunotherapy Toxicity: Immune Checkpoint Inhibitors
Neeraj Chhabra et al.
JOURNAL OF MEDICAL TOXICOLOGY (2021)
Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer
Zhenyu Ding et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
A Nanoscale Metal-Organic Framework to Mediate Photodynamic Therapy and Deliver CpG Oligodeoxynucleotides to Enhance Antigen Presentation and Cancer Immunotherapy
Kaiyuan Ni et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches
Maria Tagliamonte et al.
CANCER LETTERS (2020)
Current issues and perspectives in PD-1 blockade cancer immunotherapy
Kenji Chamoto et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)
Development of tumour peptide vaccines: From universalization to personalization
Minjun Ma et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2020)
TLR-4 Signaling vs. Immune Checkpoints, miRNAs Molecules, Cancer Stem Cells, and Wingless-Signaling Interplay in Glioblastoma Multiforme-Future Perspectives
Jakub Litak et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
Patrick A. Ott et al.
CELL (2020)
Unveiling the Hidden Treasury: CIITA-Driven MHC Class II Expression in Tumor Cells to Dig up the Relevant Repertoire of Tumor Antigens for Optimal Stimulation of Tumor Specific CD4+T Helper Cells
Greta Forlani et al.
CANCERS (2020)
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Alex D. Waldman et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Self-assembled nanovehicle-mediated co-encapsulation of inactivated EV71 virus and CpG oligonucleotides elicits potent anti-EV71 humoral and cellular immune protective responses
Hao Liang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Cytokines in clinical cancer immunotherapy
Pedro Berraondo et al.
BRITISH JOURNAL OF CANCER (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
Chimeric antigen receptor T-cell therapy - assessment and management of toxicities
Sattva S. Neelapu et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Synthetic Polymeric Mixed Micelles Targeting Lymph Nodes Trigger Enhanced Cellular and Humoral Immune Responses
Chenxi Li et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer
Daniel Rojas-Sepulveda et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Chimeric antigen receptor T cell (CAR-T) immunotherapy for solid tumors: lessons learned and strategies for moving forward
Jian Li et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
CAR-T cells: the long and winding road to solid tumors
Maria Michela D'Aloia et al.
CELL DEATH & DISEASE (2018)
The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide
Chunhui Lai et al.
THERANOSTICS (2018)
SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study
Antoni Ribas et al.
CANCER DISCOVERY (2018)
Combining immune Checkpoint inhibitors with Conventional Cancer Therapy
Yiyi Yan et al.
FRONTIERS IN IMMUNOLOGY (2018)
CAR T Cells in Solid Tumors: Blueprints for Building effective Therapies
Hannah M. Knochelmann et al.
FRONTIERS IN IMMUNOLOGY (2018)
Colorectal cancer vaccines: Tumor-associated antigens vs neoantigens
Sandra Wagner et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment
Chunmei Fu et al.
FRONTIERS IN IMMUNOLOGY (2018)
Designer vaccine nanodiscs for personalized cancer immunotherapy
Rui Kuai et al.
NATURE MATERIALS (2017)
Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine
Gao-Na Shi et al.
BIOMATERIALS (2017)
Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook
Chao Wang et al.
ADVANCED MATERIALS (2017)
Targeting CpG Adjuvant to Lymph Node via Dextran Conjugate Enhances Antitumor Immunotherapy
Weidong Zhang et al.
BIOCONJUGATE CHEMISTRY (2017)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma (vol 165, pg 35, 2016)
Willy Hugo et al.
CELL (2017)
Cancer Neoantigens and Applications for Immunotherapy
Alexis Desrichard et al.
CLINICAL CANCER RESEARCH (2016)
Immune Complexes Mimicking Synthetic Vaccine Nanoparticles for Enhanced Migration and Cross-Presentation of Dendritic Cells
Sun-Young Kim et al.
ADVANCED FUNCTIONAL MATERIALS (2016)
Targeting dendritic cells in lymph node with an antigen peptide-based nanovaccine for cancer immunotherapy
Yuan Qian et al.
BIOMATERIALS (2016)
Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
Kelly D. Moynihan et al.
NATURE MEDICINE (2016)
Cancer immunotherapy: harnessing the immune system to battle cancer
Yiping Yang
JOURNAL OF CLINICAL INVESTIGATION (2015)
Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy
Yuchen Fan et al.
VACCINES (2015)
CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases
Dennis M. Klinman et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN
Susan de Jong et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Tregs and rethinking cancer immunotherapy
Tyler J. Curiel
JOURNAL OF CLINICAL INVESTIGATION (2007)
Interleukin-12 and the regulation of innate resistance and adaptive immunity
G Trinchieri
NATURE REVIEWS IMMUNOLOGY (2003)
Share Paper
